NOAEL Studies Cosmetic Ingredient

Dichlorobenzyl Alcohol NOAEL Studies

CAS: 1777-82-8

Raw No Observed Adverse Effect Level endpoint records grouped by source. This page does not render calculated Margin of Safety values.

Back to parent ingredient page
COSMOS_DB 1 endpoint
Source Endpoint Type Value Unit Species Route Duration Study Type Reference
COSMOS_DB LOAEL 200 mg/kg bw/day rat oral 90 day Subchronic SCCNFP; J.E. Watson. 2,4-Dichlorobenzyl alcohol :13-Week Oral Toxicity Study in the Rat.The Boots Company. Study Report TX89028. 13 th March 1989
SCCNFP_vision_codex 8 endpoints
Source Endpoint Type Value Unit Species Route Duration Study Type Reference
SCCNFP_vision_codex NOAEL =100 mg/kg rat - 13 weeks NOAEL study {"dose":"At 200 mg/kg bw/day in form of a 4% solution in propylene glycol, 2,4-dichlorobenzyl alcohol did not cause hyperplasia but, instead, elicited minimal thickening of the forestomach epithelium; this change was also present (albeit at a lower incidence) in rats given propylene glycol alone.","effect":"was less marked than with propylene glycol, so it appears that propylene glycol exacerbated these effects of 2,4-dichlorobenzyl alcohol. At 200 mg/kg bw/day in form of a 4% solution in propylene glycol, 2,4-dichlorobenzyl alcohol did not cause hyperplasia but, instead, elicited minimal thickening of the forestomach epithelium; this change was also present (albeit at a lower incidence) in rats given propylene glycol alone. Thus, when 2,4-dichlorobenzyl alcohol was administered in propylene glycol, 200 mg/kg was the NOEL for hyperplasia, and 100 mg/kg was the NOEL for forestomach epithelial thickening. All of the lesions identified after 13 weeks’ of treatment were present by week 7 and no increase in the severity of the hyperplastic response appeared despite a further 6 weeks’ dosing. Once","page":7,"pdf":"out189_en.pdf","row_type":"noael_study","study_id":"out189_en_noael_001"}
SCCNFP_vision_codex NOAEL =100 mg/kg/day rabbit dermal - irritation {"citation":"Ref. : 8, 9 A review and discussion of the study results and their relevance for human safety has been carried out","dose":"The NOAEL has been identified at a dose of 100 mg/kg/day.","effect":"SCCNFP/0604/02, final Evaluation and opinion on : 2,4-Dichlorobenzyl alcohol _____________________________________________________________________________________________ 8 treatment with 2,4-dichlorobenzyl alcohol was discontinued, the epithelium rapidly returned to normal, showing that all of the lesions were fully reversible and with no evidence of autonomy. Ref. : 8, 9 A review and discussion of the study results and their relevance for human safety has been carried out. The NOAEL has been identified at a dose of 100 mg/kg/day. Ref. : 10 2.4. Irritation & corrosivity 2.4.1. Irritation (skin) On human skin (numbers of subjects not specified) no irritation occurred with 2.5% in a cream formulation on 8 successive days, although a stinging sensation was noticed if damaged skin was treated. Ref. : 1 to 4 Skin irritation studies carried out in a limited number of guinea pigs showed irritation with 5% and above in polyethyleneglycol, but not with 1%. In preliminary rabbit studies repeated dermal","page":8,"pdf":"out189_en.pdf","row_type":"noael_study","study_id":"out189_en_noael_003"}
SCCNFP_vision_codex NOAEL =100 mg/kg rat - 13 weeks NOAEL study {"dose":"At 200 mg/kg bw/day in form of a 4% solution in propylene glycol, 2,4-dichlorobenzyl alcohol did not cause hyperplasia but, instead, elicited minimal thickening of the forestomach epithelium; this change was also present (albeit at a lower incidence) in rats given propylene glycol alone.","effect":"was less marked than with propylene glycol, so it appears that propylene glycol exacerbated these effects of 2,4-dichlorobenzyl alcohol. At 200 mg/kg bw/day in form of a 4% solution in propylene glycol, 2,4-dichlorobenzyl alcohol did not cause hyperplasia but, instead, elicited minimal thickening of the forestomach epithelium; this change was also present (albeit at a lower incidence) in rats given propylene glycol alone. Thus, when 2,4-dichlorobenzyl alcohol was administered in propylene glycol, 200 mg/kg was the NOEL for hyperplasia, and 100 mg/kg was the NOEL for forestomach epithelial thickening. All of the lesions identified after 13 weeks’ of treatment were present by week 7 and no increase in the severity of the hyperplastic response appeared despite a further 6 weeks’ dosing. Once","page":7,"pdf":"out189_en.pdf","row_type":"noael_study","study_id":"out189_en_noael_001"}
SCCNFP_vision_codex NOAEL =100 mg/kg/day rabbit dermal - irritation {"citation":"Ref. : 8, 9 A review and discussion of the study results and their relevance for human safety has been carried out","dose":"The NOAEL has been identified at a dose of 100 mg/kg/day.","effect":"SCCNFP/0604/02, final Evaluation and opinion on : 2,4-Dichlorobenzyl alcohol _____________________________________________________________________________________________ 8 treatment with 2,4-dichlorobenzyl alcohol was discontinued, the epithelium rapidly returned to normal, showing that all of the lesions were fully reversible and with no evidence of autonomy. Ref. : 8, 9 A review and discussion of the study results and their relevance for human safety has been carried out. The NOAEL has been identified at a dose of 100 mg/kg/day. Ref. : 10 2.4. Irritation & corrosivity 2.4.1. Irritation (skin) On human skin (numbers of subjects not specified) no irritation occurred with 2.5% in a cream formulation on 8 successive days, although a stinging sensation was noticed if damaged skin was treated. Ref. : 1 to 4 Skin irritation studies carried out in a limited number of guinea pigs showed irritation with 5% and above in polyethyleneglycol, but not with 1%. In preliminary rabbit studies repeated dermal","page":8,"pdf":"out189_en.pdf","row_type":"noael_study","study_id":"out189_en_noael_003"}
SCCNFP_vision_codex NOAEL =100 mg/kg rat - 13 weeks NOAEL study {"dose":"At 200 mg/kg bw/day in form of a 4% solution in propylene glycol, 2,4-dichlorobenzyl alcohol did not cause hyperplasia but, instead, elicited minimal thickening of the forestomach epithelium; this change was also present (albeit at a lower incidence) in rats given propylene glycol alone.","effect":"was less marked than with propylene glycol, so it appears that propylene glycol exacerbated these effects of 2,4-dichlorobenzyl alcohol. At 200 mg/kg bw/day in form of a 4% solution in propylene glycol, 2,4-dichlorobenzyl alcohol did not cause hyperplasia but, instead, elicited minimal thickening of the forestomach epithelium; this change was also present (albeit at a lower incidence) in rats given propylene glycol alone. Thus, when 2,4-dichlorobenzyl alcohol was administered in propylene glycol, 200 mg/kg was the NOEL for hyperplasia, and 100 mg/kg was the NOEL for forestomach epithelial thickening. All of the lesions identified after 13 weeks’ of treatment were present by week 7 and no increase in the severity of the hyperplastic response appeared despite a further 6 weeks’ dosing. Once","page":7,"pdf":"out189_en.pdf","row_type":"noael_study","study_id":"out189_en_noael_001"}
SCCNFP_vision_codex NOAEL =100 mg/kg/day rabbit dermal - irritation {"citation":"Ref. : 8, 9 A review and discussion of the study results and their relevance for human safety has been carried out","dose":"The NOAEL has been identified at a dose of 100 mg/kg/day.","effect":"SCCNFP/0604/02, final Evaluation and opinion on : 2,4-Dichlorobenzyl alcohol _____________________________________________________________________________________________ 8 treatment with 2,4-dichlorobenzyl alcohol was discontinued, the epithelium rapidly returned to normal, showing that all of the lesions were fully reversible and with no evidence of autonomy. Ref. : 8, 9 A review and discussion of the study results and their relevance for human safety has been carried out. The NOAEL has been identified at a dose of 100 mg/kg/day. Ref. : 10 2.4. Irritation & corrosivity 2.4.1. Irritation (skin) On human skin (numbers of subjects not specified) no irritation occurred with 2.5% in a cream formulation on 8 successive days, although a stinging sensation was noticed if damaged skin was treated. Ref. : 1 to 4 Skin irritation studies carried out in a limited number of guinea pigs showed irritation with 5% and above in polyethyleneglycol, but not with 1%. In preliminary rabbit studies repeated dermal","page":8,"pdf":"out189_en.pdf","row_type":"noael_study","study_id":"out189_en_noael_003"}
SCCNFP_vision_codex NOAEL =100 mg/kg rat - 13 weeks NOAEL study {"dose":"At 200 mg/kg bw/day in form of a 4% solution in propylene glycol, 2,4-dichlorobenzyl alcohol did not cause hyperplasia but, instead, elicited minimal thickening of the forestomach epithelium; this change was also present (albeit at a lower incidence) in rats given propylene glycol alone.","effect":"was less marked than with propylene glycol, so it appears that propylene glycol exacerbated these effects of 2,4-dichlorobenzyl alcohol. At 200 mg/kg bw/day in form of a 4% solution in propylene glycol, 2,4-dichlorobenzyl alcohol did not cause hyperplasia but, instead, elicited minimal thickening of the forestomach epithelium; this change was also present (albeit at a lower incidence) in rats given propylene glycol alone. Thus, when 2,4-dichlorobenzyl alcohol was administered in propylene glycol, 200 mg/kg was the NOEL for hyperplasia, and 100 mg/kg was the NOEL for forestomach epithelial thickening. All of the lesions identified after 13 weeks’ of treatment were present by week 7 and no increase in the severity of the hyperplastic response appeared despite a further 6 weeks’ dosing. Once","page":7,"pdf":"out189_en.pdf","row_type":"noael_study","study_id":"out189_en_noael_001"}
SCCNFP_vision_codex NOAEL =100 mg/kg/day rabbit dermal - irritation {"citation":"Ref. : 8, 9 A review and discussion of the study results and their relevance for human safety has been carried out","dose":"The NOAEL has been identified at a dose of 100 mg/kg/day.","effect":"SCCNFP/0604/02, final Evaluation and opinion on : 2,4-Dichlorobenzyl alcohol _____________________________________________________________________________________________ 8 treatment with 2,4-dichlorobenzyl alcohol was discontinued, the epithelium rapidly returned to normal, showing that all of the lesions were fully reversible and with no evidence of autonomy. Ref. : 8, 9 A review and discussion of the study results and their relevance for human safety has been carried out. The NOAEL has been identified at a dose of 100 mg/kg/day. Ref. : 10 2.4. Irritation & corrosivity 2.4.1. Irritation (skin) On human skin (numbers of subjects not specified) no irritation occurred with 2.5% in a cream formulation on 8 successive days, although a stinging sensation was noticed if damaged skin was treated. Ref. : 1 to 4 Skin irritation studies carried out in a limited number of guinea pigs showed irritation with 5% and above in polyethyleneglycol, but not with 1%. In preliminary rabbit studies repeated dermal","page":8,"pdf":"out189_en.pdf","row_type":"noael_study","study_id":"out189_en_noael_003"}
ToxValDB_ECHA_IUCLID 3 endpoints
Source Endpoint Type Value Unit Species Route Duration Study Type Reference
ToxValDB_ECHA_IUCLID NOAEL =100 mg/kg bw/day Rat oral subchronic; 7 weeks subchronic QUALITY=2 (reliable with restrictions); STORED_SOURCE_RECORD=https://clowder.edap-cluster.com/files/669eadafe4b0a7c65d1c5747; RECORD_SOURCE_LEVEL=Extraction document; SOURCE_URL=https://echa.europa.eu/; SUBSOURCE_URL=https://echa.europa.eu/registration-dossier/-/registered-dossier/23988/7/6/2?documentUUID=79bc58c4-20a6-4535-961e-cc9dc8513507; YEAR=1986; ORIGINAL_YEAR=1986; STUDY_GROUP=ECHA IUCLID:15839396:M:--; QC_CATEGORY=Programmatically extracted from structured data source; Source overall passed QC, but this record was not manually checked; QC_STATUS=not determined; SOURCE_HASH=ToxValhc_d2d3eee148b3a6bd17a73248adf00c3a
ToxValDB_ECHA_IUCLID NOAEL =400 mg/kg bw/day Rat oral subchronic; 13 weeks subchronic QUALITY=1 (reliable without restriction); STORED_SOURCE_RECORD=https://clowder.edap-cluster.com/files/669eadafe4b0a7c65d1c575b; RECORD_SOURCE_LEVEL=Extraction document; SOURCE_URL=https://echa.europa.eu/; SUBSOURCE_URL=https://echa.europa.eu/registration-dossier/-/registered-dossier/23988/7/6/2?documentUUID=79bc58c4-20a6-4535-961e-cc9dc8513507; YEAR=1986; ORIGINAL_YEAR=1986; STUDY_GROUP=ECHA IUCLID_dup_Repeated Dose Toxicity Oral_15841644_15841645:M/F:--; QC_CATEGORY=Programmatically extracted from structured data source; Source overall passed QC, but this record was not manually checked; QC_STATUS=not determined; SOURCE_HASH=ToxValhc_6e030cd8ef7a0b1c072bfdac011d1067
ToxValDB_ECHA_IUCLID NOAEL <200 mg/kg bw/day Rat oral subchronic; 13 weeks subchronic QUALITY=1 (reliable without restriction); STORED_SOURCE_RECORD=https://clowder.edap-cluster.com/files/669eadafe4b0a7c65d1c575b; RECORD_SOURCE_LEVEL=Extraction document; SOURCE_URL=https://echa.europa.eu/; SUBSOURCE_URL=https://echa.europa.eu/registration-dossier/-/registered-dossier/23988/7/6/2?documentUUID=79bc58c4-20a6-4535-961e-cc9dc8513507; YEAR=1986; ORIGINAL_YEAR=1986; STUDY_GROUP=ECHA IUCLID_dup_Repeated Dose Toxicity Oral_15841644_15841645:M/F:--; QC_CATEGORY=Programmatically extracted from structured data source; Source overall passed QC, but this record was not manually checked; QC_STATUS=not determined; SOURCE_HASH=ToxValhc_ecdc23b7b9b16f3994b16049283e3c2c
UnifiedCodex:SCCNFP:beta.noael_studies 3 endpoints
Source Endpoint Type Value Unit Species Route Duration Study Type Reference
UnifiedCodex:SCCNFP:beta.noael_studies - 100 mg/kg rat - 13 weeks - SOURCE_SUBDIR=out189_en; REPORT_TITLE=OPINION OF THE SCIENTIFIC COMMITTEE ON COSMETIC PRODUCTS AND NON-FOOD PRODUCTS INTENDED FOR CONSUMERS CONCERNING 2,4-DICHLOROBENZYL ALCOHOL (DCBA) COLIPA n° P74; OPINION_NUMBER=SCCNFP/0604/02; COMMITTEE=SCCNFP; REPORT_DATE=adopted by the SCCNFP on 10 January 2003; VALUE_TEXT=100; DOSE=At 200 mg/kg bw/day in form of a 4% solution in propylene glycol, 2,4-dichlorobenzyl alcohol did not cause hyperplasia but, instead, elicited minimal thickening of the forestomach epithelium; this change was also present (albeit at a lower incidence) in rats given propylene glycol alone.; EFFECT=was less marked than with propylene glycol, so it appears that propylene glycol exacerbated these effects of 2,4-dichlorobenzyl alcohol. At 200 mg/kg bw/day in form of a 4% solution in propylene glycol, 2,4-dichlorobenzyl alcohol did not cause hyperplasia but, instead, elicited minimal thickening of the forestomach epithelium; this change was also present (albeit at a lower incidence) in rats given propylene glycol alone. Thus, when 2,4-dichlorobenzyl alcohol was administered in propylene glycol, 200 mg/kg was the NOEL for hyperplasia, and 100 mg/kg was the NOEL for forestomach epithelial thickening. All of the lesions identified after 13 weeks’ of treatment were present by week 7 and no increase in the severity of the hyperplastic response appeared despite a further 6 weeks’ dosing. Once; CITATION_NUMBERS=[]; DETAILS_JSON={"cas_number":"1777-82-8","citation":"","dose":"At 200 mg/kg bw/day in form of a 4% solution in propylene glycol, 2,4-dichlorobenzyl alcohol did not cause hyperplasia but, instead, elicited minimal thickening of the forestomach epithelium; this change was also present (albeit at a lower incidence) in rats given propylene glycol alone.","duration":"13 weeks","effect":"was less marked than with propylene glycol, so it appears that propylene glycol exacerbated these effects of 2,4-dichlorobenzyl alcohol. At 200 mg/kg bw/day in form of a 4% solution in propylene glycol, 2,4-dichlorobenzyl alcohol did not cause hyperplasia but, instead, elicited minimal thickening of the forestomach epithelium; this change was also present (albeit at a lower incidence) in rats given propylene glycol alone. Thus, when 2,4-dichlorobenzyl alcohol was administered in propylene glycol, 200 mg/kg was the NOEL for hyperplasia, and 100 mg/kg was the NOEL for forestomach epithelial thickening. All of the lesions identified after 13 weeks’ of treatment were present by week 7 and no increase in the severity of the hyperplastic response appeared despite a further 6 weeks’ dosing. Once","endpoint":"","ingredient":"s are also destined “for other uses”, mostly","loael_value":"","noael_unit":"mg/kg","noael_value":"100","page":7,"route":"","species":"rat","study_id":"out189_en_noael_001"}
UnifiedCodex:SCCNFP:beta.noael_studies - 100 mg/kg rat - 13 weeks - SOURCE_SUBDIR=out189_en; REPORT_TITLE=OPINION OF THE SCIENTIFIC COMMITTEE ON COSMETIC PRODUCTS AND NON-FOOD PRODUCTS INTENDED FOR CONSUMERS CONCERNING 2,4-DICHLOROBENZYL ALCOHOL (DCBA) COLIPA n° P74; OPINION_NUMBER=SCCNFP/0604/02; COMMITTEE=SCCNFP; REPORT_DATE=adopted by the SCCNFP on 10 January 2003; VALUE_TEXT=100; DOSE=At 200 mg/kg bw/day in form of a 4% solution in propylene glycol, 2,4-dichlorobenzyl alcohol did not cause hyperplasia but, instead, elicited minimal thickening of the forestomach epithelium; this change was also present (albeit at a lower incidence) in rats given propylene glycol alone.; EFFECT=so it appears that propylene glycol exacerbated these effects of 2,4-dichlorobenzyl alcohol. At 200 mg/kg bw/day in form of a 4% solution in propylene glycol, 2,4-dichlorobenzyl alcohol did not cause hyperplasia but, instead, elicited minimal thickening of the forestomach epithelium; this change was also present (albeit at a lower incidence) in rats given propylene glycol alone. Thus, when 2,4-dichlorobenzyl alcohol was administered in propylene glycol, 200 mg/kg was the NOEL for hyperplasia, and 100 mg/kg was the NOEL for forestomach epithelial thickening. All of the lesions identified after 13 weeks’ of treatment were present by week 7 and no increase in the severity of the hyperplastic response appeared despite a further 6 weeks’ dosing. Once; CITATION_NUMBERS=[]; DETAILS_JSON={"cas_number":"1777-82-8","citation":"","dose":"At 200 mg/kg bw/day in form of a 4% solution in propylene glycol, 2,4-dichlorobenzyl alcohol did not cause hyperplasia but, instead, elicited minimal thickening of the forestomach epithelium; this change was also present (albeit at a lower incidence) in rats given propylene glycol alone.","duration":"13 weeks","effect":"so it appears that propylene glycol exacerbated these effects of 2,4-dichlorobenzyl alcohol. At 200 mg/kg bw/day in form of a 4% solution in propylene glycol, 2,4-dichlorobenzyl alcohol did not cause hyperplasia but, instead, elicited minimal thickening of the forestomach epithelium; this change was also present (albeit at a lower incidence) in rats given propylene glycol alone. Thus, when 2,4-dichlorobenzyl alcohol was administered in propylene glycol, 200 mg/kg was the NOEL for hyperplasia, and 100 mg/kg was the NOEL for forestomach epithelial thickening. All of the lesions identified after 13 weeks’ of treatment were present by week 7 and no increase in the severity of the hyperplastic response appeared despite a further 6 weeks’ dosing. Once","endpoint":"","ingredient":"s are also destined “for other uses”, mostly","loael_value":"","noael_unit":"mg/kg","noael_value":"100","page":7,"route":"","species":"rat","study_id":"out189_en_noael_002"}
UnifiedCodex:SCCNFP:beta.noael_studies irritation 100 mg/kg/day rabbit dermal - irritation SOURCE_SUBDIR=out189_en; REPORT_TITLE=OPINION OF THE SCIENTIFIC COMMITTEE ON COSMETIC PRODUCTS AND NON-FOOD PRODUCTS INTENDED FOR CONSUMERS CONCERNING 2,4-DICHLOROBENZYL ALCOHOL (DCBA) COLIPA n° P74; OPINION_NUMBER=SCCNFP/0604/02; COMMITTEE=SCCNFP; REPORT_DATE=adopted by the SCCNFP on 10 January 2003; VALUE_TEXT=100; DOSE=The NOAEL has been identified at a dose of 100 mg/kg/day.; EFFECT=SCCNFP/0604/02, final Evaluation and opinion on : 2,4-Dichlorobenzyl alcohol _____________________________________________________________________________________________ 8 treatment with 2,4-dichlorobenzyl alcohol was discontinued, the epithelium rapidly returned to normal, showing that all of the lesions were fully reversible and with no evidence of autonomy. Ref. : 8, 9 A review and discussion of the study results and their relevance for human safety has been carried out. The NOAEL has been identified at a dose of 100 mg/kg/day. Ref. : 10 2.4. Irritation & corrosivity 2.4.1. Irritation (skin) On human skin (numbers of subjects not specified) no irritation occurred with 2.5% in a cream formulation on 8 successive days, although a stinging sensation was noticed if damaged skin was treated. Ref. : 1 to 4 Skin irritation studies carried out in a limited number of guinea pigs showed irritation with 5% and above in polyethyleneglycol, but not with 1%. In preliminary rabbit studies repeated dermal; CITATION=Ref. : 8, 9 A review and discussion of the study results and their relevance for human safety has been carried out; CITATION_NUMBERS=[8,9]; REFERENCE=Ref. : 8, 9 A review and discussion of the study results and their relevance for human safety has been carried out; DETAILS_JSON={"cas_number":"1777-82-8","citation":"Ref. : 8, 9 A review and discussion of the study results and their relevance for human safety has been carried out","dose":"The NOAEL has been identified at a dose of 100 mg/kg/day.","duration":"","effect":"SCCNFP/0604/02, final Evaluation and opinion on : 2,4-Dichlorobenzyl alcohol _____________________________________________________________________________________________ 8 treatment with 2,4-dichlorobenzyl alcohol was discontinued, the epithelium rapidly returned to normal, showing that all of the lesions were fully reversible and with no evidence of autonomy. Ref. : 8, 9 A review and discussion of the study results and their relevance for human safety has been carried out. The NOAEL has been identified at a dose of 100 mg/kg/day. Ref. : 10 2.4. Irritation & corrosivity 2.4.1. Irritation (skin) On human skin (numbers of subjects not specified) no irritation occurred with 2.5% in a cream formulation on 8 successive days, although a stinging sensation was noticed if damaged skin was treated. Ref. : 1 to 4 Skin irritation studies carried out in a limited number of guinea pigs showed irritation with 5% and above in polyethyleneglycol, but not with 1%. In preliminary rabbit studies repeated dermal","endpoint":"irritation","ingredient":"s are also destined “for other uses”, mostly","loael_value":"","noael_unit":"mg/kg/day","noael_value":"100","page":8,"route":"dermal","species":"rabbit","study_id":"out189_en_noael_003"}
openFDA substances 4 endpoints
Source Endpoint Type Value Unit Species Route Duration Study Type Reference
openFDA substances FDA UNII substance identifier 1NKX3648J9 UNII - - - chemical {"approval_status":null,"molecular_formula":"C7H6Cl2O","source_table":"substance_identifiers_fda","substance_class":"chemical","unii_code":"1NKX3648J9"}
openFDA substances FDA UNII substance identifier 1NKX3648J9 UNII - - - chemical {"approval_status":null,"molecular_formula":"C7H6Cl2O","source_table":"substance_identifiers_fda","substance_class":"chemical","unii_code":"1NKX3648J9"}
openFDA substances FDA UNII substance identifier 1NKX3648J9 UNII - - - chemical {"approval_status":null,"molecular_formula":"C7H6Cl2O","source_table":"substance_identifiers_fda","substance_class":"chemical","unii_code":"1NKX3648J9"}
openFDA substances FDA UNII substance identifier 1NKX3648J9 UNII - - - chemical {"approval_status":null,"molecular_formula":"C7H6Cl2O","source_table":"substance_identifiers_fda","substance_class":"chemical","unii_code":"1NKX3648J9"}